ES2188521T3 - Preparado farmaceutico de uso en medicina y veterinaria para regenerar la flora intestinal en diarrea o sindrome dispeptico. - Google Patents

Preparado farmaceutico de uso en medicina y veterinaria para regenerar la flora intestinal en diarrea o sindrome dispeptico.

Info

Publication number
ES2188521T3
ES2188521T3 ES00914133T ES00914133T ES2188521T3 ES 2188521 T3 ES2188521 T3 ES 2188521T3 ES 00914133 T ES00914133 T ES 00914133T ES 00914133 T ES00914133 T ES 00914133T ES 2188521 T3 ES2188521 T3 ES 2188521T3
Authority
ES
Spain
Prior art keywords
medicine
diarrhea
regenerate
pharmaceutical preparation
syndrome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES00914133T
Other languages
English (en)
Inventor
Giovanna Galli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Italmed SNC di Galli Giovanna e Pacini Gigliola
Original Assignee
Italmed SNC di Galli Giovanna e Pacini Gigliola
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Italmed SNC di Galli Giovanna e Pacini Gigliola filed Critical Italmed SNC di Galli Giovanna e Pacini Gigliola
Application granted granted Critical
Publication of ES2188521T3 publication Critical patent/ES2188521T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/12—Magnesium silicate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Un preparado farmacéutico para uso en medicina y veterinaria para regenerar la flora intestinal o el síndrome dispéptico (colitis, diarrea, enteritis inespecífica), para la profilaxis y tratamiento de la descompensación microbiana intestinal después del uso de antibióticos, para enfermedades digestivas del recién nacido que recibe lactancia artificial y para las enfermedades digestivas de los animales de granja y mascotas, que contiene bacterias ácido lácticas vivas y caracterizado porque contiene una sal cálcica añadida y una sal de aluminio añadida.
ES00914133T 1999-03-15 2000-03-15 Preparado farmaceutico de uso en medicina y veterinaria para regenerar la flora intestinal en diarrea o sindrome dispeptico. Expired - Lifetime ES2188521T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999FI000051A IT1307850B1 (it) 1999-03-15 1999-03-15 Composizione farmaceutica a base di fermenti lattici e carboidratinon assorbibili contenente un sale di calcio ed un sale di alluminio

Publications (1)

Publication Number Publication Date
ES2188521T3 true ES2188521T3 (es) 2003-07-01

Family

ID=11352845

Family Applications (1)

Application Number Title Priority Date Filing Date
ES00914133T Expired - Lifetime ES2188521T3 (es) 1999-03-15 2000-03-15 Preparado farmaceutico de uso en medicina y veterinaria para regenerar la flora intestinal en diarrea o sindrome dispeptico.

Country Status (7)

Country Link
EP (1) EP1162987B1 (es)
AT (1) ATE228001T1 (es)
AU (1) AU3555800A (es)
DE (1) DE60000825T2 (es)
ES (1) ES2188521T3 (es)
IT (1) IT1307850B1 (es)
WO (1) WO2000054788A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6383534B1 (en) * 2000-01-18 2002-05-07 Lorin Dyrr Mineral water composition
KR100419132B1 (ko) 2000-12-29 2004-02-18 조성근 위·장 점막 부착성과 증식성, 내산성, 내담즙성 및헬리코박터 파일로리, 대장균 0157:ｈ7에 대한 항균성이우수한 락토바실러스 파라카제이 서브스패시즈 파라카제이ｃｓｋ 01
DE10104055A1 (de) * 2001-01-31 2002-08-14 Suedzucker Ag Verwendung von Kohlenhydraten zur Beseitigung von Darminfektionen bei Tieren
WO2003013558A1 (en) * 2001-07-30 2003-02-20 Claudio De Simone Treatment of radiation-induced diarrhea with probiotics
US6936598B2 (en) * 2003-11-21 2005-08-30 Hill's Pet Nutrition, Inc. Composition and method
CA2470090A1 (fr) 2004-06-18 2005-12-18 Bio-K Plus International Inc. Bacteries lactiques et leurs usages dans la prevention de diarrhee associee aux antibiotiques
WO2006097949A1 (en) * 2005-03-16 2006-09-21 Actial Farmacêutica, Lda. Mixture of at least 6 species of lactic acid bacteria and/or bifidobacteria in the manufacture of sourdough
ES2277550B1 (es) * 2005-12-21 2008-06-16 Laboratorios Casen-Fleet, S.L. Kit farmaceutico para la preparacion de una sal de hidratacion con un probiotico para bebes.
EP2286836A4 (en) 2008-04-17 2011-10-12 Ajinomoto Kk IMMUNOSTIMULATING AGENT
DE102008059070B4 (de) * 2008-11-26 2019-05-16 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung zur therapeutischen oder prophylaktischen Behandlung von Durchfallerkrankungen und/oder zur Aufrechterhaltung und/oder Wiederherstellung der natürlichen Darmflora, Dosiereinheit, Verpackungseinheit und Verwendung der Zusammensetzung
FI122247B (fi) * 2009-08-12 2011-10-31 Vetcare Oy Probioottinen valmiste koiran maha- ja suolistokanavassa ilmenevien häiriöiden ennaltaehkäisemiseksi tai hoitamiseksi
FR2974512B1 (fr) * 2011-04-28 2013-11-08 Roquette Freres Composition anti-inflammatoire de l'intestin comprenant du maltitol
EP2604123A1 (en) 2011-12-15 2013-06-19 Friesland Brands B.V. Method and nutritional compositions for the treatment of diarrhea.
ITMI20131467A1 (it) * 2013-09-06 2015-03-07 Sofar Spa Uso di una composizione comprendente microrganismi per aumentare la produzione intestinale di acido butirrico, di acido folico o di niacina e/o per diminuire la produzione intestinale di acido succinico
MA39710A (fr) 2014-04-23 2015-10-29 Sofar Spa Composition topique destinée à être utilisée dans le traitement d'une maladie inflammatoire de l'intestin
MA45327A (fr) 2016-05-13 2019-03-20 Sofar Spa Utilisation de probiotiques pour améliorer l'absorption des protéines
MA45288A (fr) 2016-06-08 2019-04-17 Sofar Spa Nouvelle utilisation médicale de probiotiques
IT201600122724A1 (it) 2016-12-02 2018-06-02 Sofar Spa Exopolysaccharides and uses thereof
IT201600127498A1 (it) 2016-12-16 2018-06-16 Sofar Spa Probiotici per uso nella diverticolosi e malattia diverticolare
CN108203702A (zh) * 2016-12-20 2018-06-26 北京中科星冠生物技术股份有限公司 一种复合益生菌解酒饮料及其专用复合益生菌
CN108030096A (zh) * 2017-12-18 2018-05-15 浙江民生健康科技有限公司 一种钙铁锌与益生菌组合物及其应用
US11751597B2 (en) 2019-11-05 2023-09-12 Alfasigma S.P.A. Compositions comprising bacterial strains for use in increasing the bioavailability of amino acids derived from proteins, and related food product methods and systems

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI84874C (fi) * 1989-11-02 1992-02-10 Valio Meijerien Foerfarande foer inkapsling av biologiskt aktiva aemnen, enligt metoden framstaelld kapsel, dess anvaendning och foder innehaollande den.
FR2674755B1 (fr) * 1991-04-05 1995-02-03 Thorel Jean Noel Nouvelles compositions medicamenteuses immunostimulatrices.
WO1993000012A1 (en) * 1991-06-28 1993-01-07 Pioneer Hi-Bred Internatinal, Inc. Manipulation of intestinal structure and enzymes in animals
SE513815C2 (sv) * 1995-08-25 2000-11-06 Wasa Medicals Ab Förfarande för framställning av tabletter innehållande levande mikroorganismer och med oligosacharider i tablettmaterialet

Also Published As

Publication number Publication date
ITFI990051A0 (it) 1999-03-15
WO2000054788A1 (en) 2000-09-21
IT1307850B1 (it) 2001-11-19
ATE228001T1 (de) 2002-12-15
AU3555800A (en) 2000-10-04
ITFI990051A1 (it) 2000-09-15
EP1162987B1 (en) 2002-11-20
DE60000825T2 (de) 2003-09-04
DE60000825D1 (de) 2003-01-02
EP1162987A1 (en) 2001-12-19

Similar Documents

Publication Publication Date Title
ES2188521T3 (es) Preparado farmaceutico de uso en medicina y veterinaria para regenerar la flora intestinal en diarrea o sindrome dispeptico.
Li Current status and prospects for in-feed antibiotics in the different stages of pork production—A review
Papatsiros et al. Effect of benzoic acid and combination of benzoic acid with a probiotic containing Bacillus Cereus var. toyoi in weaned pig nutrition
ES2567296T3 (es) Procedimiento para usar una cepa de Bacillus subtilis para potenciar la salud animal
Kritas et al. Evaluation of probiotics as a substitute for antibiotics in a large pig nursery
US20200281227A1 (en) Reducing the risk of viral infection due to viral contaminated feed
US20220338504A1 (en) Feed additive compositions
AR098251A2 (es) Uso de aivlosin o de una sal de adición ácida del mismo farmacológicamente aceptada para la preparación de un medicamento de uso veterinario, un alimento para aves de corral o cerdos, una composición recubierta estable para ser agregada a dicho alimento y un medicamento de uso veterinario
Henn et al. Inclusion of porcine spray-dried plasma in broiler diets
ES2481918T3 (es) Composición de huesos de dátiles para el tratamiento de animales
Rizzo et al. Antimicrobial resistance and current alternatives in veterinary practice: A review
Hofacre et al. Efficacy of butyric and valeric acid esters in a necrotic enteritis challenge model
JP2024501786A (ja) 抗微生物剤組成物とその製造方法及びその製品
ES2817623T3 (es) Aditivo de complemento alimenticio
US20150351428A1 (en) Methods and compositions for orally dosing postnatal swine
Nutricionales et al. Mode of action of Bacillus subtilis and efficiency in piglet feeding
Chiba et al. The therapeutic efficacy of allyl isothiocyanate in cows with bovine digital dermatitis
RU2157696C2 (ru) Способ лечения скрытого мастита у коров
AU2003233814B2 (en) Ketoprofen-supplemented animal feed and use thereof in the simultaneous treatment of a group of animals for processes which are accompanied by fever, inflammation and/or pain
RU2629814C1 (ru) Препарат для лечения желудочно-кишечных болезней телят, протекающих с признаками диареи
Tabashsum et al. Acceptable alternative growth promoters for organic farm animal production
Bhunia Microbes as a tool to defend against antibiotic resistance in food animal production
Giannenas Organic acids in pig and poultry nutrition
Chatterjee et al. Global use of antimicrobials in food animals, emergence of antimicrobial resistance and way forward: an overview
Hill et al. Case Study: Control of respiratory disease in male Holstein calves with tildipirosin and effect on health and growth from 0 to 4 months of age